XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Product revenue $ 7,766 $ 495 $ 10,905 $ 1,092
Total revenues 7,766 495 10,905 1,092
Cost of goods sold (1,519) (150) (2,422) (331)
Gross profit 6,247 345 8,483 761
Operating expenses:        
Research and development expenses 3,394 3,555 7,094 8,131
Selling, general and administrative expenses 6,765 4,787 15,579 8,952
Total operating expenses 10,159 8,342 22,673 17,083
Operating loss (3,912) (7,997) (14,190) (16,322)
Change in fair value of warrant liability (9,755) 1,160 (10,367) 1,160
Interest expense, net (84) (371) (283) (1,059)
Other (expense) income 10 6 (12) 19
Net loss (13,741) (7,202) (24,852) (16,202)
Other comprehensive (loss) income:        
Unrealized gain (loss) on investments (141) 0 (133) 0
Foreign currency translation adjustments (8) 0 6 19
Total comprehensive loss $ (13,890) $ (7,202) $ (24,979) $ (16,183)
Common share data:        
Basic loss per common share (in dollars per share) $ (0.48) $ (0.58) $ (0.93) $ (1.35)
Diluted loss per common share (in dollars per share) $ (0.48) $ (0.58) $ (0.93) $ (1.35)
Weighted average number of basic shares outstanding (in shares) 28,364,731 12,463,665 26,625,955 12,035,738
Weighted average number of diluted shares outstanding (in shares) 28,364,731 12,463,665 26,625,955 12,035,738